Crohn's vs Ulcerative Colitis: Key Differences Explained

What is inflammatory bowel disease (IBD)?

IBD is a term for chronic immune-mediated inflammation in the digestive tract. It is not the same as irritable bowel syndrome (IBS), which involves bowel dysfunction without structural inflammation. The two main forms of IBD are Crohn's disease and ulcerative colitis. In a small proportion of cases — often when inflammation is confined to the colon but the pattern does not clearly fit either — the condition is called indeterminate colitis or inflammatory bowel disease unclassified (IBDU) 1Ref 1Lichtenstein GR, Loftus EV, Isaacs KL, Regueiro MD, Gerson LB, Sands BE (2018).ACG Clinical Guideline: Management of Crohn's Disease in Adults.Crohn's disease characteristics: transmural inflammation, skip lesions, small bowel involvement, fistula risk, aminosalicylate limitations, and surgical non-curability2Ref 2Rubin DT, Ananthakrishnan AN, Siegel CA, Sauer BG, Long MD (2019).ACG Clinical Guideline: Ulcerative Colitis in Adults.Ulcerative colitis characteristics: limited to colon, mucosal inflammation, rectal involvement, rectal bleeding, aminosalicylate efficacy, and curative surgery option.

Where does inflammation occur in each condition?

Crohn's disease [1] - Can involve *any* part of the GI tract from mouth to anus - Most commonly affects the terminal ileum (end of the small intestine) and beginning of the large intestine - Inflammation is often *patchy* — inflamed areas separated by normal tissue (called skip lesions) - Involves *all layers* of the bowel wall (transmural), predisposing to fistulas, abscesses, and strictures

Ulcerative colitis [2] - Limited to the *large intestine (colon) and rectum* - Starts in the rectum and extends continuously upward — never skips segments - Affects only the *inner lining* (mucosa) of the colon - Does not involve the small intestine (except in the rare phenomenon of backwash ileitis)

This location difference has major implications for diagnosis and surgical options.

How do the symptoms compare?

Shared symptoms - Chronic diarrhea - Abdominal pain and cramping - Fatigue and weight loss - Extraintestinal manifestations: joint pain (arthritis), eye inflammation (uveitis, episcleritis), skin conditions (erythema nodosum, pyoderma gangrenosum), and liver involvement (primary sclerosing cholangitis — more common in UC)

Differences in presentation

| Feature | Crohn's | Ulcerative Colitis | |---|---|---| | Blood in stool | Less consistent; may not occur | Very common; often a defining feature | | Abdominal pain location | Often right lower quadrant (ileocolic) | Often left lower quadrant or diffuse | | Fistulas / abscesses | Yes — due to transmural inflammation | Rare | | Small bowel involvement | Common | No | | Rectal involvement | ~50% | Almost always (starts in rectum) |

UC tends to produce more consistent rectal bleeding; Crohn's is more likely to cause strictures, fistulas, and nutritional complications from small bowel involvement 1Ref 1Lichtenstein GR, Loftus EV, Isaacs KL, Regueiro MD, Gerson LB, Sands BE (2018).ACG Clinical Guideline: Management of Crohn's Disease in Adults.Crohn's disease characteristics: transmural inflammation, skip lesions, small bowel involvement, fistula risk, aminosalicylate limitations, and surgical non-curability2Ref 2Rubin DT, Ananthakrishnan AN, Siegel CA, Sauer BG, Long MD (2019).ACG Clinical Guideline: Ulcerative Colitis in Adults.Ulcerative colitis characteristics: limited to colon, mucosal inflammation, rectal involvement, rectal bleeding, aminosalicylate efficacy, and curative surgery option.

How is each condition diagnosed?

Diagnosis for both involves colonoscopy with biopsies, which allows direct visualization of the pattern and distribution of inflammation and sampling of tissue for pathology review. Additional imaging — MRI or CT enterography — is typically used in Crohn's to evaluate small bowel involvement that colonoscopy cannot reach. Blood tests (CRP, ESR, CBC) and stool biomarkers (fecal calprotectin) support diagnosis and monitoring but are not diagnostic alone 3Ref 3National Institute of Diabetes and Digestive and Kidney Diseases (2023).Crohn's Disease.Patient-facing overview of Crohn's disease definition, symptoms, diagnosis including imaging, and comparison with UC4Ref 4National Institute of Diabetes and Digestive and Kidney Diseases (2023).Ulcerative Colitis.Patient-facing overview of ulcerative colitis definition, symptoms, diagnosis, and comparison with Crohn's.

Are treatments the same?

There is meaningful overlap — many drug classes are used in both conditions — but there are important differences:

• Aminosalicylates (5-ASA drugs) have a well-established role in ulcerative colitis for mild to moderate disease; their benefit in Crohn's disease is more limited 1Ref 1Lichtenstein GR, Loftus EV, Isaacs KL, Regueiro MD, Gerson LB, Sands BE (2018).ACG Clinical Guideline: Management of Crohn's Disease in Adults.Crohn's disease characteristics: transmural inflammation, skip lesions, small bowel involvement, fistula risk, aminosalicylate limitations, and surgical non-curability2Ref 2Rubin DT, Ananthakrishnan AN, Siegel CA, Sauer BG, Long MD (2019).ACG Clinical Guideline: Ulcerative Colitis in Adults.Ulcerative colitis characteristics: limited to colon, mucosal inflammation, rectal involvement, rectal bleeding, aminosalicylate efficacy, and curative surgery option.
• Biologics targeting TNF, integrin (vedolizumab), and IL-12/23 (ustekinumab) are approved for both conditions, though specific approvals differ by agent.
• Surgery in UC can be curative — removal of the colon eliminates the disease at that site. Surgery in Crohn's is not curative because inflammation can recur in new locations 1Ref 1Lichtenstein GR, Loftus EV, Isaacs KL, Regueiro MD, Gerson LB, Sands BE (2018).ACG Clinical Guideline: Management of Crohn's Disease in Adults.Crohn's disease characteristics: transmural inflammation, skip lesions, small bowel involvement, fistula risk, aminosalicylate limitations, and surgical non-curability2Ref 2Rubin DT, Ananthakrishnan AN, Siegel CA, Sauer BG, Long MD (2019).ACG Clinical Guideline: Ulcerative Colitis in Adults.Ulcerative colitis characteristics: limited to colon, mucosal inflammation, rectal involvement, rectal bleeding, aminosalicylate efficacy, and curative surgery option.

This distinction — that UC surgery is potentially curative while Crohn's surgery is not — is one of the most meaningful practical differences between the two conditions.

Colorectal cancer risk and surveillance

Long-standing colonic inflammation from IBD — particularly extensive ulcerative colitis — raises the long-term risk of colorectal cancer. Current guidelines recommend that colonoscopy surveillance begin 8 to 10 years after symptom onset, with intervals guided by disease extent and risk factors 5Ref 5Shaukat A, Kahi CJ, Burke CA, Rabeneck L, Sauer BG, Rex DK (2021).ACG Clinical Guidelines: Colorectal Cancer Screening 2021.Colorectal cancer screening and surveillance recommendations, including context for IBD-related surveillance starting 8-10 years after symptom onset. People with Crohn's disease involving a substantial portion of the colon carry a similar risk and follow analogous surveillance schedules. Your gastroenterologist will set your surveillance interval based on your personal disease history.

Which one is 'worse'?

That framing is not especially useful — both can range from mild and manageable to severely disabling, depending on disease extent, response to treatment, and complications. Crohn's disease affecting the small intestine carries significant risk of nutritional deficiency and stricture-related surgery. Ulcerative colitis affecting the whole colon carries a meaningful long-term colorectal cancer risk requiring regular surveillance. Both require ongoing specialist management.

If you have recently received an IBD diagnosis, a gastroenterologist is the right specialist to guide your evaluation and treatment planning. Gale can help you prepare questions and coordinate that referral.